Safety of Drugs in Pregnancy

Pregnancy complicates therapeutic decision-making in dermatology due to evolving safety data and patient-specific risks. This session reviews the evidence surrounding dermatologic drug use across pregnancy stages. APPs will learn to weigh maternal needs against fetal safety and how to counsel patients effectively. A practical framework for prescribing and risk communication will be provided.